Literature DB >> 28975464

Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.

Sherif Hafez1,2,3, Mohammed Abdelsaid4, Susan C Fagan1,2,5, Adviye Ergul6,7,8.   

Abstract

Matrix metalloprotease-3 (MMP3) activation mediates the tissue plasminogen activator (tPA)-induced hemorrhagic transformation after stroke. Hyperglycemia (HG) further exacerbates this outcome. We have recently shown that HG increases MMP3 activity in the brain after stroke. However, the combined HG-tPA effect on MMP3 activation, and the mechanisms through which MMP3 is activated were not previously reported. Accordingly, this study tested the hypothesis that tPA and HG increases MMP3 activity in the brain after stroke through peroxynitrite induced tyrosine nitration. Normoglycemic and mildly hyperglycemic male Wistar rats were subjected to middle cerebral artery suture occlusion for 90 min or thromboembolic occlusion, and up to 24 h reperfusion, with and without tPA. MMP3 activity and tyrosine nitration were evaluated in brain homogenates at 24 h. Brain microvascular endothelial cells (BMVEC) were subjected to either 3 h hypoxia or 6 h OGD under either normal or high glucose conditions with or without tPA, with or without peroxynitrite scavenger, FeTPPs. MMP3 activity and MMP3 tyrosine nitration were assessed at 24 h. HG and tPA significantly increased activity and tyrosine nitration of MMP3 in the brain. In BMVECs, tPA but not HG increased MMP3 activity. Treating BMVEC with FeTPPs significantly reduced the tPA-induced increase in MMP3 activity and nitration. Augmented oxidative and nitrative stress may be potential mechanisms contributing to MMP3 activation in hyperglycemic stroke, especially with tPA administration. Peroxynitrite may be playing a critical role in mediating MMP3 activation through tyrosine nitration in hyperglycemic stroke.

Entities:  

Keywords:  Hemorrhagic transformation; Hyperglycemia; Matrix metalloprotease 3; Peroxynitrite; Tissue plasminogen activator

Mesh:

Substances:

Year:  2017        PMID: 28975464      PMCID: PMC5801117          DOI: 10.1007/s11064-017-2411-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

Review 1.  Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; P Pathak; H C Gerstein
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

Review 2.  Role of matrix metalloproteinase-3 in neurodegeneration.

Authors:  Eun-Mee Kim; Onyou Hwang
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

3.  Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.

Authors:  Eduardo Candelario-Jalil; Jeffrey Thompson; Saeid Taheri; Mark Grossetete; John C Adair; Elaine Edmonds; Jillian Prestopnik; John Wills; Gary A Rosenberg
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

Review 4.  Increased oxidative stress during hyperglycemic cerebral ischemia.

Authors:  Chantal Bémeur; Line Ste-Marie; Jane Montgomery
Journal:  Neurochem Int       Date:  2007-03-14       Impact factor: 3.921

Review 5.  Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2014-04-26       Impact factor: 7.616

6.  Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

Authors:  Yasuhiro Suzuki; Nobuo Nagai; Kasumi Yamakawa; Junichi Kawakami; H Roger Lijnen; Kazuo Umemura
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

7.  Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.

Authors:  Askiel Bruno; Thomas A Kent; Bruce M Coull; Ravi R Shankar; Chandan Saha; Kyra J Becker; Brett M Kissela; Linda S Williams
Journal:  Stroke       Date:  2007-12-20       Impact factor: 7.914

8.  Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.

Authors:  Y Suzuki; N Nagai; K Umemura; D Collen; H R Lijnen
Journal:  J Thromb Haemost       Date:  2007-05-21       Impact factor: 5.824

9.  MMP-3 activation is a hallmark indicating an early change in TMJ disorders, and is related to nitration.

Authors:  H Fujita; T Morisugi; Y Tanaka; T Kawakami; T Kirita; Y Yoshimura
Journal:  Int J Oral Maxillofac Surg       Date:  2008-12-30       Impact factor: 2.789

10.  Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.

Authors:  Weiguo Li; Zhi Qu; Roshini Prakash; Connie Chung; Handong Ma; Md Nasrul Hoda; Susan C Fagan; Adviye Ergul
Journal:  Brain Res       Date:  2013-10-19       Impact factor: 3.252

View more
  9 in total

Review 1.  Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.

Authors:  Chengli Liu; Jie Xie; Shanshan Sun; Hui Li; Tianyu Li; Chao Jiang; Xuemei Chen; Junmin Wang; Anh Le; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Cell Mol Neurobiol       Date:  2020-10-30       Impact factor: 5.046

2.  Short-Term Acute Exercise Preconditioning Reduces Neurovascular Injury After Stroke Through Induced eNOS Activation.

Authors:  Sherif Hafez; Mohammad Badruzzaman Khan; Mohamed E Awad; Jesse D Wagner; David C Hess
Journal:  Transl Stroke Res       Date:  2019-12-20       Impact factor: 6.829

Review 3.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

4.  Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.

Authors:  Kelly M DeMars; Austin O McCrea; David M Siwarski; Brian D Sanz; Changjun Yang; Eduardo Candelario-Jalil
Journal:  Front Neurosci       Date:  2018-02-20       Impact factor: 4.677

5.  Curcumin and its analog alleviate diabetes-induced damages by regulating inflammation and oxidative stress in brain of diabetic rats.

Authors:  Chengfeng Miao; Hanbin Chen; Yulian Li; Ying Guo; Feifei Xu; Qi Chen; Yanyan Zhang; Mengjun Hu; Guorong Chen
Journal:  Diabetol Metab Syndr       Date:  2021-02-18       Impact factor: 3.320

6.  Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines.

Authors:  Yihe Wang; Christine Y Chuang; Clare L Hawkins; Michael J Davies
Journal:  Antioxidants (Basel)       Date:  2022-08-20

Review 7.  Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy.

Authors:  Lexiao Li; Madison N Sluter; Ying Yu; Jianxiong Jiang
Journal:  Pharmacol Res       Date:  2020-10-11       Impact factor: 7.658

Review 8.  Small molecules targeting cyclooxygenase/prostanoid cascade in experimental brain ischemia: Do they translate?

Authors:  Jianxiong Jiang; Ying Yu
Journal:  Med Res Rev       Date:  2020-10-22       Impact factor: 12.944

9.  Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice.

Authors:  Saifudeen Ismael; Sanaz Nasoohi; Arum Yoo; Heba A Ahmed; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2020-03-14       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.